Figure 2From: Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccinesPlasmid DNA expressing mouse tyrosinase used in clinical trials at MSKCC. The full length murine tyrosinase cDNA was cloned into a bacterial expression vector having a kanamycin resistance cassette and operating under the host's constitutive CMV promoter for expressionBack to article page